Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer
Status:
Unknown status
Trial end date:
2021-03-31
Target enrollment:
Participant gender:
Summary
The investigators propose to evaluate the efficacy of the combination of Pd-1 Monoclonal
Antibody and HPV Vaccine in the patients with cervical cancer who fails in or can not endure
the standard treatment